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Medicine, University of Twente, Enschede, The NetherlandsABSTRACT Conventional methods to determine the aggregation number, that is, the number of monomers per oligomer,
struggle to yield reliable results for large protein aggregates, such as amyloid oligomers. We have previously demonstrated
the use of a combination of single-molecule photobleaching and substoichiometric fluorescent labeling to determine the aggre-
gation number of oligomers of human a-synuclein, implicated in Parkinson’s disease. We show here that this approach is
capable of accurately resolving mixtures of multiple distinct molecular species present in the same sample of dopamine-induced
a-synuclein oligomers, and that we can determine the respective aggregation numbers of each species from a single histogram
of bleaching steps. We found two distinct species with aggregation numbers of 15–19 monomers and 34–38 monomers. These
results show that this single-molecule approach allows for the systematic study of the aggregation numbers of complex supra-
molecular assemblies formed under different aggregation conditions.INTRODUCTIONThe neuronal protein a-synuclein (aS) is an intrinsically
disordered protein consisting of 140 amino acids (1). aS is
considered to be at the basis of Parkinson’s disease, a human
neurodegenerative disease characterized by the formation of
intraneuronal Lewy bodies and the loss of dopaminergic
neurons (2). Although Lewy bodies are composed largely
of fibrillar aggregates of aS (3), a number of studies show
that oligomeric aggregates are significantly more cytotoxic
than the fibrils, indicating that oligomers play an essential
role in the disease mechanism (4–7).
Depending on the aggregation conditions, a variety of
oligomeric species are found, differing in terms of structure,
morphology, toxicity, and aggregation number, that is, the
number of monomers forming an oligomer (7–11). Struc-
tural and biophysical information on the different oligomers
is essential to understanding the aggregation process and
determining whether there is a specific cytotoxic oligomeric
species or whether oligomers in general cause cell death, but
such information is scarce.
Conventional methods to determine the aggregation num-
ber of oligomeric protein aggregates, such as mass spec-
trometry and size-exclusion chromatography, have failed
to yield reliable results for amyloid oligomers. Recently,
we showed that single-molecule photobleaching in combi-Submitted July 2, 2013, and accepted for publication December 3, 2013.
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0006-3495/14/01/0440/7 $2.00nation with substoichiometric labeling can be used to accu-
rately determine the aggregation number of aS oligomers
formed at high aS concentrations (12). In our method we
fluorescently label a small fraction of the monomeric sub-
units, as opposed to conventional photobleaching where
all monomeric subunits of the oligomer are fluorescently
labeled.
Sequential photobleaching of all fluorescent labels incor-
porated in a single oligomer generates discrete steps in the
fluorescence intensity. For conventional photobleaching,
where all monomers are labeled, counting the number
of steps directly provides the number of monomers per
oligomer (13,14). However, it is impossible to accurately
determine the number of photobleaching steps for oligo-
meric aggregates consisting of many labeled monomeric
subunits. The intensity decrease converges to an exponen-
tially decaying curve making the individual bleaching
steps indistinguishable (15). Furthermore, a large number
of fluorescent labels may influence the aggregation process,
resulting in structurally and functionally different oligo-
meric aggregates.
These problems can be overcome by using substoi-
chiometric labeling, where only a small fraction of the
monomeric subunits is labeled. Aggregating a mixture of
labeled and unlabeled monomers is a stochastic process
that results in a distribution in the number of fluorescently
labeled monomers per oligomer, even for homogeneous
oligomers of the same aggregation number (see Fig. 1).
The average number of fluorescent labels per oligomer
and hence the average number of photobleaching steps,
can be optimized by tuning the exact label density, that is,
the ratio of labeled to unlabeled monomers at the initiation
of the aggregation. As a result, we can accurately determine
the number of photobleaching steps even for large
protein aggregates. However, in contrast to conventionalhttp://dx.doi.org/10.1016/j.bpj.2013.12.009
FIGURE 1 Using a substoichiometric mixture
of fluorescently labeled and unlabeled monomers
for aggregation will result in oligomers containing
different numbers of fluorescently labeled mono-
mers. Counting the number of bleaching steps for
a statistically relevant number of oligomers will
result in a distribution of bleaching steps that can
be linked to the total number of monomers per
oligomer via the label density chosen at the initia-
tion of aggregation and the label PMF. If oligomers
of different aggregation numbers are present, the
measured histogram of bleaching steps will consist
of the sum of binomial distributions. By fitting the
appropriate number of species, it is possible to
obtain the aggregation number of multiple species
from a single histogram of bleaching steps. To see
this figure in color, go online.
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from a single oligomer does not directly yield the number
of monomers forming the oligomer due to the stochastic na-
ture of aggregation. Now, the distribution in the number of
fluorescent labels per oligomer is linked to the mean number
of monomers per oligomer via the label density and the label
probability mass function (PMF). The label PMF gives the
probability that an oligomer with a defined number ofmonomers contains a specific number of labels. To accu-
rately determine the aggregation number of the oligomer,
it is essential to analyze a statistically relevant number of
oligomers to determine the entire distribution in the number
of labels per oligomer.
aSoligomers formed in the presenceofdopamineare of spe-
cial interest, because the selective loss of dopaminergic neu-
rons suggests that dopamine plays a role in the formation ofBiophysical Journal 106(2) 440–446
442 Zijlstra et al.cytotoxic aS oligomers (16). Previous studies byConway et al.
showed that the addition of dopamine can stabilize aS oligo-
mers, preventing them from maturing into fibrils (17). Cappai
et al. showed that dopamine accelerates the formation of non-
amyloidogenic, sodium-dodecyl-sulfate-resistant aS oligo-
mers (8). A range of biophysical techniques have been used
to study the morphology of dopamine-induced oligomers,
indicating a variety of different shapes and sizes (8,17,18),
without providing insights into the exact aggregation number
of these oligomers. Interestingly, there is considerable discus-
sion about whether dopamine forms covalent or noncovalent
bondswith the aS. Clearly, these interactions have an influence
on the formation of the oligomers (17,19).
In this work, we study the aggregation number, or molec-
ular composition, of dopamine-induced aS oligomers.MATERIALS AND METHODS
Instrumentation and measurement procedure
The photobleaching experiments were performed using a custom-built
inverted confocal microscope, similar to the one described in our previous
study (12). In short, as excitation source, we used a pulsed diode laser
(LDH-D-C-640, Picoquant, Berlin, Germany) operating at 640 nm at a repe-
tition rate of 20 MHz. An epi-illumination configuration was used, i.e., the
illumination and emission collection are through the same microscope
objective (UPLSAPO 60W, 60, 1.2NA, Olympus, Center Valley, PA).
The remaining excitation light in the detection path was suppressed with a
long-pass filter (664 nm; Razoredge, Semrock, Rochester, NY) and a band-
pass filter (Brightline, 708/75 nm; Semrock). The emission was spatially
filtered using a 30 mm pinhole and was subsequently focused onto a single-
photon avalanche diode (SPCM-APQR-16, PerkinElmer, Waltham, MA),
connected to a photon counting module (PicoHarp300, Picoquant).
The initial scanning of the sample was done at a high scanning speed,
2 ms per pixel, and low excitation power, ~50 W/cm2, to prevent dye
bleaching. We then located individual oligomers in the initial area scan,
see Section S1 in the Supporting Material, localized them in the focus of
the microscope objective, and subsequently collected fluorescence intensity
time traces from distinct oligomers. To record the time trace, we used
higher excitation powers, ~750 W/cm2, to make sure that each dye mole-
cule photobleached. Typical time traces are shown in Section S2 in the
Supporting Material.a-Synuclein labeling, aggregation, and oligomer
purification
Expression and purification of aS wild-type and mutant aS A140C was
performed as previously described (19).
Before labeling, aS A140C in 10 mM Tris-HCl and 5 mM NaCl, pH 7.4,
was reduced with a sixfold molar excess of dithiothreitol (DTT) for 30 min
at room temperature. The samples were desalted using a Pierce Zeba desalt-
ing column. A twofold molar excess of Alexa Fluor 647 C2 maleimide (Life
Technologies, Invitrogen, Carlsbad, CA) was added and incubated for 1 h in
the dark at room temperature. Free label was removed using two consecu-
tive desalting steps. The labeling efficiency was determined from the
absorption spectrum. The protein concentration was determined from the
absorbance at 276 nm using an extinction coefficient of 5745 M1 cm1,
and the Alexa Fluor 647 concentration from the absorbance at 650 nm using
an extinction coefficient of 239,000 M1 cm1. Subsequently, aS wild-type
in 10 mM Tris-HCl, pH 7.4, was added to the labeled aS A140C to obtain
the desired ratio between wild-type and A140C aS.Biophysical Journal 106(2) 440–446To prepare the aS oligomers, we optimized a protocol previously
described in the literature to generate oligomers within an acceptable
timeframe at the required yields (8). In short, the mixture of labeled and
wild-type aS was dried in a vacuum evaporator and dissolved in 10 mM
phosphate buffer, pH 7.4, at a final protein concentration of 140 mM. Dopa-
mine was added at a final concentration of 200 mM and the solution was
incubated for 3 h at 37C. To protect the dopamine from light-induced
degradation, we kept the sample in the dark during the entire aggregation
time. To remove very large aggregates, the solution was filtered using a
0.22 mm spin filter. The oligomers were purified by size-exclusion chroma-
tography on a Superdex200 gel filtration column using 10 mMTris-HCl and
50 mM NaCl, pH7.4, as eluent. The fractions containing the aS oligomers
were identified by the absorbance at both 276 nm and 650 nm. A typical
elution profile is shown in Section S3 in the Supporting Material.Sample preparation for single-molecule
spectroscopy
Microscope glass coverslips were cleaned by placing them for at least 1 h in
an ultraviolet/ozone cleaner (UV/Ozone ProCleaner Plus; Bioforce, San
Diego, CA). The oligomers must be immobilized to be studied. To realize
this, the isolated oligomers were diluted to ~1 nM in water and directly spin-
coated for 10 s at 6000 rpm on top of a cleaned coverslip. The samples con-
tained the oligomers at low concentrations, so that the oligomers were well
separated and did not overlap within the diffraction limit of the microscope.Fitting procedure
For the single species, the histograms of bleaching steps were fitted with a
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where A is the total number of events, n the number of trials, k the number
of successes, and p the probability of success, which in this case is the same
as the label density.
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All fitting was done using OriginPro 9.0 64-Bit.RESULTS AND DISCUSSION
To study the aggregation number of dopamine-induced aS
oligomers, we prepared Alexa Fluor 647 fluorescently
labeled dopamine-induced oligomers with different label
densities and analyzed bleaching traces for a minimum of
100 distinct oligomers per label density. To verify the sto-
chastic incorporation of labeled aS into the oligomer, we
compared the elution profiles of wild-type oligomers
without fluorescent labels and the Alexa Fluor 647 labeled
oligomers. We observe no difference in the peak position
of the elution profile, and therefore conclude that the fluo-
rescent label does not influence the aggregation process
(see Section S4 in the Supporting Material).
Fig. 2 a shows the photobleaching histogram for dopa-
mine-induced aS oligomers with a 20% label density built
FIGURE 2 Experimental histograms of bleaching steps for dopamine-
induced oligomers with a 20% label density built from bleaching traces
of 105 distinct oligomers. (a) The histogram is fitted with a single (blue
dash-dotted line) binomial distribution that does not represent the measured
distribution accurately. (b) The histogram is fitted with a combination of
two (solid red line) and three (black squares) binomial distributions that
fit the histogram well. To see this figure in color, go online.
FIGURE 3 Simulated histogram of bleaching steps for a mixture of two
oligomeric species consisting of 20 and 35 monomers per oligomer and pre-
sent in equal fractions. The histogram is clearly broadened and has a lower
peak value compared to the single-species fit (black dash-dotted line),
whereas a two-species fit fully explains both the width and the height of
the histogram. To see this figure in color, go online.
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The stochastic incorporation of labeled monomers in the
oligomers is described by a classical Bernoulli process in
which there is no preference for either labeled or unlabeled
monomers. Assuming that there is only a single species of
oligomer present, as seen before for oligomers prepared us-
ing a different protocol (12), the bleaching histogram was
fitted with a single binomial distribution from which the
average number of monomers per oligomer was obtained
(Fig. 2 a, blue dash-dotted line). The fit, however, does
not represent the data well. The histogram has a significantly
lower peak value compared to the fit and displays a clear
broadening, especially on the right side of the histogram.
The difference between the measured distribution and the
fit is much larger than we observed previously for oligomers
present in a single, well-defined species (12). Clearly, if the
oligomers are present in multiple species instead of a single
species, the distribution of bleaching steps will change
significantly.To test whether we can discriminate multiple species pre-
sent in the same sample from a single histogram of bleach-
ing steps, we simulated a histogram of bleaching steps for a
mixture of two oligomeric species consisting of 20 and 35
monomers per oligomer (see Fig. 3). This histogram of
bleaching steps consists of more than one binomial distri-
bution. As a consequence, a single-species fit cannot
adequately explain the histogram of bleaching steps (see
Fig. 3, black dash-dotted line, for single-species fit).
Compared to the single-species fit, the simulated histogram
is clearly broadened, especially on the right side of the his-
togram, and has a lower peak value compared to the fit. The
simulated histogram, however, can be adequately explained
if a sum of multiple binomial distributions is fitted (see
Fig. 3, red solid line). Moreover, this indicates that it is
possible to obtain the aggregation number of multiple spe-
cies from a single histogram of bleaching steps.
For the single-species fit of the experimental data corre-
sponding to a 20% label density, we observe discrepancies
similar to those seen for the single-species fit of the simu-
lated histogram, suggesting that the dopamine-induced olig-
omers are composed of multiple species. A two-species fit
of the experimental histogram of bleaching steps for the
oligomers with 20% label density greatly improved the fit
quality (see Fig. 2 b, red solid line), where both the peak
height and the width of the histogram are now fitted well.
The fit quality is characterized by the reduced c-squared
parameter (see Table 1). Upon adding a third species
(Fig. 2 b, black squares), the algorithm finds two essentially
identical species (17 and 18 monomers per oligomer),
whereas the third species contains 32 monomers per olig-
omer. However, the three-species fit has a reduced fit quality
compared to the two-species fit (see Table 1). We thereforeBiophysical Journal 106(2) 440–446
TABLE 1 Reduced c-squared parameter for the one-, two-,
and three-species fits and corresponding aggregation
numbers of the oligomers
Reduced c-squared parameter Aggregation number
1 species 4.8 21
2 species 2.1 17/31
3 species 2.6 17/18/32
FIGURE 4 Histogram of bleaching steps for dopamine-induced oligo-
mers with a 20%, 15%, and 10% label density, each built from bleaching
traces of at least 100 distinct oligomers. The histograms are fitted with a
combination of two binomial distributions (solid black lines). The mean
values of the two binomial distributions give the mean numbers of mono-
mers per oligomer for both species. The mean numbers of monomers per
oligomer are determined to be 175 2 and 315 6 for the 20% label density,
185 1 and 365 2 for the 15% label density, and 235 3 and 445 14 for
the 10% label density.
444 Zijlstra et al.conclude that two distinct oligomeric species are sufficient
to explain the data fully.
When using the combination of single-molecule photo-
bleaching and substoichiometric labeling, it is very impor-
tant to use label densities for which the technique works
optimally (12). Difficulties arise when using a label density
that is either too low or too high. Choosing the appropriate
label density becomes even more important if the oligomers
are present in multiple species. Since both species have a
different aggregation number, the label density has to be
chosen in such a way that both aggregation numbers can
be determined accurately.
To determine the optimal label density, we have to
consider the following for both species. When using a lower
label density, an increasing fraction of the oligomers will not
contain a fluorescent label due to the stochastic nature of ag-
gregation and are therefore invisible to this method. Because
this fraction cannot be measured, it is not included in the
histogram and will cause an uncertainty in the fitting. The
larger the fraction of oligomers without a label, the larger
is the uncertainty in the fitting, resulting in an overestima-
tion of the number of monomers per oligomer. Clearly, for
a two-species system, overestimating the aggregation num-
ber of the smaller species will also influence the aggregation
number found for the larger species.
On the other hand, using a too-high label density will
result in problems similar to those encountered with conven-
tional photobleaching. The intensity decay will converge to
an exponentially decaying curve, making it impossible to
accurately determine the number of bleaching steps. As a
consequence, those oligomers containing too many labels
will not be included in the histogram, resulting in an under-
estimation of the number of monomers per oligomer.
To obtain optimal results, it is thus necessary to choose
the label density in such a way that neither species suffers
from either of these biases. To verify that the 20% label den-
sity we used is within the optimal range of label densities
and hence gives accurate results for the aggregation number
of both species, we also determined the photobleaching
histograms for dopamine-induced aS oligomers with label
densities of 15% and 10%, each built from bleaching traces
of at least 100 distinct oligomers (see Fig. 4). There is, as
expected, a clear shift of the histograms to a lower number
of bleaching steps with decreasing label density, since a
lower label density results in a lower average number of
labels per oligomer. Each label density was fitted with a
combination of two binomial distributions, and the meanBiophysical Journal 106(2) 440–446number of monomers per oligomer was determined for
both species (Fig. 4, solid lines). The experimental error is
given by the uncertainty in the mean number of monomers
per oligomer determined from the fitted binomial distribu-
tions and not by the width of the distribution, since aggre-
gation is a stochastic process that always results in a
distribution in the observed number of bleaching steps.
The mean numbers of monomers per oligomer are deter-
mined to be 175 2 and 315 6 for the 20% label density,
185 1 and 365 2 for the 15% label density, and 235 3
and 44 5 14 for the 10% label density. The numbers of
monomers that form an oligomer are, within the error
bars, identical for the 20% and 15% label densities. To
test whether the aggregation protocol reproducibly yields
the same oligomers, we prepared a second batch of oligo-
mers with a 15% label density. We found identical aggrega-
tion numbers (175 2 and 355 4) for this preparation (see
Section S5 in the Supporting Material).
Aggregation Number of a-Synuclein Oligomers 445For the 10% label density, we observe deviations that can
be explained by the low label density. For this label density,
the mean number of bleaching steps for the smaller
species of the dopamine-induced oligomers is <2. In this
case, >15% of the oligomers do not contain a fluorescent
label due to the stochastic nature of the aggregation process
and are hence not included in the histogram of bleaching
steps. This will result in the observed overestimation of
the aggregation number. This severe overestimation of the
aggregation number of the smaller species also results in
an overestimation of the number of monomers in the larger
species. The uncertainty in the number of monomers per
oligomer for the 10% label density is also reflected by the
correspondingly large experimental error compared to that
found for the 15% label density.
For the 20% label density, we find a small deviation in the
larger, second species compared to the 15% label density,
which can be attributed to the large number of bleaching
steps. The mean number of bleaching steps for the larger
species of the dopamine-induced oligomers is>7, which re-
sults in ~10% of the oligomers containing >10 fluorescent
labels. As we have shown previously, 10 bleaching steps
is at the limit of what can still be accurately determined
from a time trace (12). This results in the observed underes-
timation of the aggregation number for the larger species,
which is also reflected by the larger experimental error
compared to the error found for the 15% label density.
The presence of oligomers with no labels, and oligomers
with too many labels, limits the range of label densities
within which the technique of single-molecule photobleach-
ing in combination with substoichiometric labeling can be
used. The optimal label density depends on the aggregation
number and the heterogeneity of the protein aggregates. As
explained above, if the mean number of labels is <2, >15%
of the oligomers do not contain a fluorescent label. There-
fore, as an estimate, the lowest suitable label density follows
from the rule that the mean number of bleaching steps, and
hence the mean number of labels, needs to be at least 2. The
mean number of bleaching steps is given by the product
of the label density and the aggregation number. For
the oligomers studied here, using the smallest aggregation
number found for the 15% label density of 18 monomers/
oligomer as a reference value, the lowest suitable label
density is ~11%.
On the other hand, if the mean number of labels is about
8, >15% of the oligomers will contain too many labels and
will not be analyzable. Therefore, the highest suitable label
density can be estimated according to the rule that the mean
number of bleaching steps should be ~8. For the oligomers
studied here, taking the largest aggregation number found
for the 15% label density of 36 monomers/oligomer, the
highest suitable label density is ~22%.
We cannot, however, resolve a small heterogeneity of the
number of monomers per oligomer within each species.
Such a range of species would result in a broadening ofthe histogram of bleaching steps compared to the fit, which
is very difficult to observe if a sum of binomials is fitted.
Furthermore, adding more species to the fit did not improve
the fit or yield distinctly different values, indicating that
possible additional species must have aggregation numbers
similar to the species already found. Therefore, the largest
heterogeneity within each species is given by the uncer-
tainty in the mean number of monomers per oligomer.
Our data clearly show that dopamine-induced oligomers
formed under these conditions are present in two species.
As a control, we also analyzed oligomers that are formed
under identical aggregation conditions but in the absence
of dopamine. We find that the oligomers formed in the
absence of dopamine also display a bimodal distribution
but with clearly different aggregation numbers (see Section
S6 in the Supporting Material). Our single-molecule photo-
bleaching experiments indicate that oligomer formation
depends much on the experimental conditions. Our previous
published work (12), where aS was aggregated at high con-
centrations and for long incubation times yielded a single
species of aggregation number ~30. The protocol used
here, using low aS concentrations and short aggregation
times in the presence or absence of dopamine gave rise to
distinctly different oligomers. Dopamine clearly has a spe-
cific effect on oligomer formation, leading to larger aggre-
gation numbers for both detectable species. It has been
reported that dopamine is incorporated into oligomers
(20). The difference in oligomer aggregation number
observed in the presence of dopamine likely results from
the dopamine-mediated changes in interactions between
the aS monomers. There is considerable discussion about
whether dopamine forms covalent or noncovalent bonds
with aS (16,18), although we are not in a position to distin-
guish between these possibilities with this technique. We
note that the dopamine concentrations used are high
compared to reported physiological concentrations (21),
although it is reasonable to assume that the dopamine
concentration is elevated in the substantia nigra.
The two species observed at shorter aggregation times, in
both the presence and absence of dopamine, is a fundamen-
tally different result than what we found for aS oligomers
prepared using a different protocol based on a high concen-
tration of aS and long aggregation times (12). For these olig-
omers, we found a single, well-defined species of oligomers.
Section S7 in the Supporting Material shows the histogram
of bleaching steps obtained for these oligomers, with a 15%
label density fitted with both a single species and two spe-
cies. Both fits give exactly the same aggregation number,
with the two-species fit having a worse reduced c-squared
parameter. The finding from this work that dopamine-
induced oligomers are present in two distinct species high-
lights that aS oligomers are indeed a heterogeneous family
of aggregates in which the molecular details of the oligo-
mers strongly depend on the conditions under which the
oligomers form.Biophysical Journal 106(2) 440–446
446 Zijlstra et al.CONCLUSION
We have determined the aggregation number of dopamine-
induced aS oligomers using the combination of single-mole-
cule photobleaching and substoichiometric labeling. Using
this combination of techniques, we are even able to distin-
guish multiple distinct species present in the same sample
and determine their respective aggregation numbers from
a single histogram of bleaching steps. We show that dopa-
mine-induced aS oligomers are present in two clearly
different species. We found a small species consisting of
15–19 monomers per oligomer and a larger species of 34–
38 monomers per oligomer. The small spread in the number
of monomers determined per species might reflect small
variations in the number of monomers per oligomer. How-
ever, the current data do not allow us to resolve the details
of the aggregation number within the individual species.
Interestingly, the numbers found suggest that the larger spe-
cies might be a dimer of the smaller species. We do not see
any indications of the presence of even larger assemblies,
such as tetramers, which should be detectable at the 10% la-
bel density. The relative fractions obtained from the fit indi-
cate that both species are present in about the same fraction.
Our results show that aS forms oligomers of a defined num-
ber of monomers and that there is not a wide distribution in
the number of monomers per oligomer. Depending on the
conditions, oligomers of different aggregation number are
formed. The technique of single-molecule photobleaching
of substoichiometrically labeled aS oligomers allows for
the sensitive detection of subtle changes in the molecular
composition and aggregation number, and makes possible a
systematic study of the influence of the aggregation condi-
tions on the aggregation number of the oligomers formed.
Our current finding of species of distinct aggregation
number implies that oligomers organize in a stable structure,
but that the structure depends on the aggregation conditions.
Linking the well-defined aggregation number and specific
structure of the oligomers to their cytotoxicity may allow
insights into the cause of Parkinson’s disease and provide
specific targets for pharmaceutical intervention.
SUPPORTING MATERIAL
Seven figures are available at http://www.biophysj.org/biophysj/
supplemental/S0006-3495(13)05798-6.
We thank Anja Stefanovic for assistance with the dopamine-induced olig-
omer preparation protocol.
This work was financially supported by the Nederlandse Organisatie voor
Wetenschappelijk Onderzoek (NWO) through the NWO-CW TOP program
number 700.58.302. We also acknowledge support from the Stichting Inter-
nationaal Parkinson Fonds.
REFERENCES
1. Clayton, D. F., and J. M. George. 1998. The synucleins: a family of
proteins involved in synaptic function, plasticity, neurodegeneration
and disease. Trends Neurosci. 21:249–254.Biophysical Journal 106(2) 440–4462. Pakkenberg, B., A. Møller, ., H. Pakkenberg. 1991. The absolute
number of nerve cells in substantia nigra in normal subjects and in
patients with Parkinson’s disease estimated with an unbiased stereo-
logical method. J. Neurol. Neurosurg. Psychiatry. 54:30–33.
3. Spillantini, M. G., M. L. Schmidt,., M. Goedert. 1997. a-Synuclein
in Lewy bodies. Nature. 388:839–840.
4. Danzer, K. M., D. Haasen, ., M. Kostka. 2007. Different
species of a-synuclein oligomers induce calcium influx and seeding.
J. Neurosci. 27:9220–9232.
5. Fink, A. L. 2006. The aggregation and fibrillation of a-synuclein. Acc.
Chem. Res. 39:628–634.
6. Outeiro, T. F., P. Putcha, ., P. J. McLean. 2008. Formation of toxic
oligomeric a-synuclein species in living cells. PLoS ONE. 3:e1867.
7. Winner, B., R. Jappelli, ., R. Riek. 2011. In vivo demonstration
that a-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. USA.
108:4194–4199.
8. Cappai, R., S. L. Leck,., A. F. Hill. 2005. Dopamine promotes a-syn-
uclein aggregation into SDS-resistant soluble oligomers via a distinct
folding pathway. FASEB J. 19:1377–1379.
9. De Franceschi, G., E. Frare,., P. P. de Laureto. 2011. Structural and
morphological characterization of aggregated species of a-synuclein
induced by docosahexaenoic acid. J. Biol. Chem. 286:22262–22274.
10. Na¨sstro¨m, T., T. Fagerqvist,., J. Bergstro¨m. 2011. The lipid peroxi-
dation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote
the formation of a-synuclein oligomers with distinct biochemical,
morphological, and functional properties. Free Radic. Biol. Med.
50:428–437.
11. van Rooijen, B. D., M. M. A. E. Claessens, and V. Subramaniam. 2009.
Lipid bilayer disruption by oligomeric a-synuclein depends on bilayer
charge and accessibility of the hydrophobic core. Biochim. Biophys.
Acta. 1788:1271–1278.
12. Zijlstra, N., C. Blum,., V. Subramaniam. 2012. Molecular composi-
tion of sub-stoichiometrically labeled a-synuclein oligomers deter-
mined by single-molecule photobleaching. Angew. Chem. Int. Ed.
Engl. 51:8821–8824.
13. Ding, H., P. T. Wong,., D. G. Steel. 2009. Determination of the olig-
omer size of amyloidogenic protein b-amyloid(1–40) by single-mole-
cule spectroscopy. Biophys. J. 97:912–921.
14. Dukes, K. D., C. F. Rodenberg, and R. K. Lammi. 2008. Monitoring
the earliest amyloid-b oligomers via quantized photobleaching of
dye-labeled peptides. Anal. Biochem. 382:29–34.
15. Eggeling, C., J. Widengren,., C. A. M. Seidel. 1998. Photobleaching
of fluorescent dyes under conditions used for single-molecule detec-
tion: evidence of two-step photolysis. Anal. Chem. 70:2651–2659.
16. Rekas, A., R. Cappai, ., C. Le Lan Pham. 2014. Dopamine-induced
a-synuclein oligomers. In Bio-Nanoimaging. V. N. Uversky and
Y. L. Lyubchenko, editors. Academic Press, Boston, pp. 291–300.
17. Conway, K. A., J. C. Rochet,., P. T. Lansbury, Jr. 2001. Kinetic sta-
bilization of the a-synuclein protofibril by a dopamine-a-synuclein
adduct. Science. 294:1346–1349.
18. Leong, S. L., C. L. L. Pham,., R. Cappai. 2009. Formation of dopa-
mine-mediated a-synuclein-soluble oligomers requires methionine
oxidation. Free Radic. Biol. Med. 46:1328–1337.
19. Herrera, F. E., A. Chesi,., P. Carloni. 2008. Inhibition of a-synuclein
fibrillization by dopamine is mediated by interactions with five C-ter-
minal residues and with E83 in the NAC region. PLoS ONE. 3:e3394.
20. Rekas, A., R. B. Knott, ., C. L. Pham. 2010. The structure of dopa-
mine induced a-synuclein oligomers. Eur. Biophys. J. 39:1407–1419.
21. Mosharov, E. V., K. E. Larsen,., D. Sulzer. 2009. Interplay between
cytosolic dopamine, calcium, and a-synuclein causes selective death of
substantia nigra neurons. Neuron. 62:218–229.
